Orthoplastics China Expansion

The expansion of Orthoplastics China has taken place over many years. Kelvin Wu has represented us in this territory and has been instrumental in securing our success. As part of our planned growth in this region and within Asia generally, Mr Wu has now been appointed as our official representative for China, Japan and Korea.

In addition to Kelvin’s new geographic responsibilities, we have expanded the role of Bernadette Dabbs to include sales, marketing and account management, in addition to her already successful leadership of our customer services team.

Orthoplastics is solely dedicated to the medical sector around the globe. There are no geographic boundaries when it comes to helping our customers. This is part of the strategic growth and expansion strategy.

We firmly believe that quality standards are maintained throughout the world because of our certification to ISO 9001, ISO 13485 and ISO 14001. The supply chain mechanism and distribution network of Orthoplastics, ensures that products can be transported to each corner of the globe, in full compliance with relevant security and safety standards. The export quality of our products is unrivalled - we are considered to be the market leaders in providing specialist guidance and support to customers in the medical sector.

The growth strategy of Orthoplastics is evidence of great leadership and rigorous quality assured products and services, ranging from cross-linked UHMWPE and Vitamin E UHMWPE, component machining, to direct compression moulding and laboratory services.